PALM and breast cancer: In a global gene expression comparison between two breast cancer cell lines, paralemmin-1 was over expressed in the invasive, estrogen-receptor (ER) negative breast cancer cell line (TMX2-28) as compared to the non-invasive ER-positive parent cell line (MCF-7)[5].